3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
201
Recruiting
55
Completed
45
Not yet recruiting
27
Active not recruiting
14
Withdrawn
8
Terminated
6
Suspended
2
Enrolling by invitation
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Osteosarcoma
1
Drug-Related Side Effects and Adverse Reactions
1
Colorectal Neoplasms
1
Interventions
Specimen Handling
12
Magnetic Resonance Spectroscopy
10
Cyclophosphamide
10
Cisplatin
7
Bevacizumab
7
pembrolizumab
6
Radiosurgery
6
Oxaliplatin
5
Nivolumab
5
Irinotecan
5
Fluorouracil
5
Everolimus
5
Capecitabine
5
Biopsy
5
venetoclax
4
fludarabine
4
S 1 (combination)
4
Prednisone
4
Leucovorin
4
Gemcitabine
4
Etoposide
4
Drug Therapy
4
Doxorubicin
4
Azacitidine
4
fludarabine phosphate
3
Vincristine
3
Taxes
3
Tacrolimus
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Suspended
×
OTHER
×
apatinib
×
Clear all
NCT04824352
2024-05-14
AIEO
Peking University People's Hospital
Phase 2
Suspended
44 enrolled
NCT03743428
2023-06-29
BABST-C
Shenzhen People's Hospital
Phase NA
Suspended
40 enrolled